For the Inventor, By the Inventor

Enter assignee name

Kanagawa, Japan

Peptidream Inc.

USPTO Granted Patents = 12

CIPO Patents = 1

EPO Patents = 6

Trademarks = 3

Forward Citations = 16

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Patrick Reid (7 out of 10 patents)

Keiichi Masuya (4 out of 4 patents)

Takashi Kawakami (3 out of 54 patents)

4. Hiroshi Murakami (3 out of 29 patents)

5. Masaki Ohuchi (3 out of 4 patents)

6. Michiharu Handa (3 out of 4 patents)

7. Michinori Kohara (2 out of 19 patents)

8. Toru Sasaki (2 out of 88 patents)

9. Kiichi Kubota (2 out of 2 patents)

10. Akihiro Nagaya (2 out of 5 patents)

11. Yoshiaki Masuda (1 out of 36 patents)

12. Takahiro Yamaguchi (1 out of 141 patents)

13. Yutaka Mori (1 out of 9 patents)

14. Hideki Kubota (1 out of 20 patents)

15. Hironao Saito (1 out of 4 patents)

12 patents: Sort by Forward Citations

1. 12528834 - Method for producing peptide compound (2026-01-20),

2. 12415834 - GhR-binding peptide and composition comprising same (2025-09-16),

3. 12351652 - Hemagglutinin-binding peptide (2025-07-08),

4. 12240871 - Method for producing peptide compound (2025-03-04),

5. 11993629 - Method for producing peptide compound (2024-05-28),

6. 11970694 - Rapid display method in translational synthesis of peptide (2024-04-30),

7. 11149066 - Thrombospondin 1-binding peptide (2021-10-19),

8. 10745692 - Production method for charged non-protein amino acid-containing peptide (2020-08-18),

9. 10711268 - Method for producing peptide library, peptide library, and screening method (2020-07-14),

10. 10632187 - Hemagglutinin-binding peptide (2020-04-28),

11. 10328143 - Hemagglutinin-binding peptide (2019-06-25),

12. 9815867 - Peptide for inhibiting vascular endothelial growth factor receptor (2017-11-14),

PeptiDream Inc. is a biopharmaceutical company focused on the discovery and development of therapeutic peptides. The company utilizes its proprietary peptide discovery platform to identify novel drug candidates for a variety of diseases. PeptiDream's technology has enabled the rapid discovery of peptide-based therapeutics with high specificity and efficacy. The company collaborates with pharmaceutical partners to bring innovative peptide drugs to market.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

12 Patents

#138 in Kanagawa

#3,926 in Japan

#48,027 in the World

Kanagawa, Japan

Peptidream Inc.

Forward Citations = 16

37 inventors:

Patrick Reid (7 out of 10 patents)

Keiichi Masuya (4 out of 4 patents)

Takashi Kawakami (3 out of 54 patents)

4. Hiroshi Murakami (3 out of 29 patents)

5. Masaki Ohuchi (3 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…